HLA-Typed Primary Cells: The advantages of working with HLA in drug development research

For those working in drug development, human leukocyte antigens or HLA are a key element to keep in mind as an essential regulator of the immune system. Watch our latest explainer video to understand the benefits of working with HLA in your pre-clinical research.


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Tell us your HLA donor requirements

Please give us your contact details. One of our scientific specialists will get in touch to handle your request.

Contact us

Choose your Region

Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.

  1. North America
    1. Canada
    2. United States
  2. Europe
    1. Austria
    2. Belgium
    3. Bulgaria
    4. Croatia
    5. Czech Republic
    6. Denmark
    7. Finland
    8. France
    9. Germany
    10. Greece
    11. Hungary
    12. Ireland
    13. Italy
    14. Liechtenstein
    15. Luxembourg
    16. Monaco
    17. Netherlands
    18. Norway
    19. Poland
    20. Portugal
    21. Romania
    22. Slovakia
    23. Slovenia
    24. Spain
    25. Sweden
    26. Switzerland
    27. United Kingdom
  3. Asia
    1. India
    2. Indonesia
    3. Israel
    4. Japan
    5. Malaysia
    6. Singapore
    7. South Korea
    8. Taiwan
    9. Thailand
Scroll to top